QC
ADPT icon

Quent Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Quent Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Hold
1,131
– – ﹤0.01% 1010
2026
Q1 		$15.7K Sell
1,131
-71
-6% -$1.13K ﹤0.01% 1057
2025
Q4 		$19.5K Hold
1,202
– – ﹤0.01% 995
2025
Q3 		$18K Buy
+1,202
New +$14.6K ﹤0.01% 897
2025
Q2 		– Sell
-1,202
Closed -$8.93K – 296
2025
Q1 		$8.93K Hold
1,202
– – ﹤0.01% 921
2024
Q4 		$7.21K Hold
1,202
– – ﹤0.01% 978
2024
Q3 		$6.15K Hold
1,202
– – ﹤0.01% 1068
2024
Q2 		$4.35K Hold
1,202
– – ﹤0.01% 1109
2024
Q1 		$3.86K Buy
1,202
+884
+278% +$3.42K ﹤0.01% 1156
2023
Q4 		$1.56K Hold
318
– – ﹤0.01% 1226
2023
Q3 		$1.73K Hold
318
– – ﹤0.01% 1196
2023
Q2 		$2.13K Hold
318
– – ﹤0.01% 1179
2023
Q1 		$2.81K Hold
318
– – ﹤0.01% 1127
2022
Q4 		$2.43K Buy
318
+71
+29% +$552 ﹤0.01% 1119
2022
Q3 		$2K Buy
+247
New +$2.33K ﹤0.01% 1074
2022
Q2 		– Sell
-193
Closed -$3K – 1161
2022
Q1 		$3K Buy
+193
New +$3.03K ﹤0.01% 1093

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quent Capital's ADPT Position: Q2 2026 in Review

Quent Capital held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 1,131 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Quent Capital first reported a position in ADPT in Q1 2022 and has held it in 16 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Quent Capital held 1,131 shares of Adaptive Biotechnologies worth $24.3K as of Q2 2026.
  • Quent Capital left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1010 holding.
  • Quent Capital first reported a position in Adaptive Biotechnologies in Q1 2022 and has held it in 16 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.